Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study.

Audrey Le BotRaphaël LecomtePierre GazeauFrançois BenezitCédric ArvieuxSéverine AnsartDavid BoutoilleRozenn Le BerreCéline ChabanneMatthieu LesouhaitierLoren DejoiesErwan FlecherJean-Marc ChapplainPierre TattevinMatthieu Revest

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

A large proportion (43.9%) of staphylococcal PVE received no rifampin. One-year survival and relapse rates were similar in patients treated with or without rifampin.

Keyphrases

staphylococcus aureus
methicillin resistant staphylococcus aureus
free survival
aortic valve
mitral valve
cross sectional
aortic stenosis
clinical trial